All In Biotech

Free tool

FAERS Monitor: Syndros

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205525 or its brand name (Syndros, Dronabinol). Reports on generic versions are filed under their own applications.

Reports

5,133

Serious

3,836

75% of reports

Hospitalization

1,804

Death reported

1,169

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea485
  • fatigue420
  • off label use388
  • diarrhoea387
  • death383
  • toxicity to various agents341
  • drug abuse309
  • vomiting281
  • decreased appetite275
  • pain253
  • weight decreased237
  • drug screen positive225
  • dyspnoea223
  • drug ineffective210
  • asthenia203

Reports by year received

View as table
YearReports
200412
200516
200622
200716
200816
200927
201036
201158
201260
201380
2014136
2015211
2016246
2017338
2018477
2019512
2020439
2021407
2022415
2023465
2024495
2025397
2026252

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,026 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug screen positiveSignal225120.0105.425,701
drug abuseSignal30915.313.74,105
toxicity to various agentsSignal3418.37.52,195
decreased appetiteSignal2754.94.3847
weight decreasedSignal2373.53.1422
nauseaSignal4852.52.3457
diarrhoeaSignal3872.52.2343
vomitingSignal2812.42.2245
astheniaSignal2032.21.9136
fatigueSignal4202.22.0288
death3831.81.7147
off label use3881.81.7148
pain2531.71.572
dyspnoea2231.61.453
drug ineffective2100.70.641

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.